慢性肾脏病血管钙化机制研究进展－抑制与促进血管钙化两类因子的重要作用
被引量：3
摘要
慢性肾脏病患者血管钙化发生率高、进展快，对慢性肾功能不全患者生存率产生重大影响。通过研究血管钙化发生机制，有望找到预防血管钙化发生，阻断血管钙化进展的有效方法。本文扼要阐明慢性肾功能不全血管钙化机制的研究进展，并着重对抑制与促进血管钙化两类因子的重要作用加以介绍。
出处
《国际泌尿系统杂志》
2008年第4期505-509,共5页
International Journal of Urology and Nephrology
参考文献25
-
1Civilibal M, Caliskan S, Adaletli I, et al. Coronary artery calcifications in children with end - stage renal disease. Pediatr Nephrol,2006 ,21 (10) :1426 - 1433.
-
2Ishimura E, Taniwaki H, Tabata T,et al. Cross - sectional association of serum phosphate with carotid intima - medial thickness in hemodialysis patients. American Journal of Kidney Dis, 2005 ,45 (5) : 859 - 865.
-
3Reynolds JL, Joannides AJ, Skepper JN. , et al. Human Vascular Smooth Muscle Cells Undergo Vesicle - Mediated Calcification in Response to Changes in Extracellular Calcium and Phosphate Concentrations: A Potential Mechanism for AcceIerated Vascular Calcification in ESRD. J Am Soc Nephrol,2004,15:2857 -2867.
-
4Neves KR, Graciolli FG, dos Reis LM,et al. Vascular calcification:contribution of parathyroid hormone in renal failure. Kidney Int, 2007,71 (12) :1262 - 1270.
-
5Gopalakrishnan R, Suttamanatwong S, Carlson AE, et al. Role of matrix G la protein in parathyroid hormone inhibition of osteoblast mineralization. Cells Tissues Organs, 2005,181 ( 3 - 4) : 166 - 175.
-
6Henley C, Colloton M, Cattley RC, et al. 1,25 - Dihydroxyvitamin D3 but not cinacalcet HC1 (Sensipar/Mimpara) treatment mediates aortic calcification in a rat mode of secondary hyperparathyroidism. Nephrol Dial Transplant, 2005, 20 (7) : 1370 - 1377.
-
7Sehurgers LJ, Teunissen K J, Knapen MH, et al. Novel conformation -specific antibodies against matrix gamma - carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification. Arterioscler Thromb Vasc Biol, 2005, 25 (8) : 1629 - 1633.
-
8Schurgers LJ, Spronk HM, Soute BA, et al. Regression of warfarin - induced medial elastocaleinosis by high intake of vitamin K in rats. Blood, 2007, 109(7) :2823 -2831.
-
9Westenfeld R, Schfer C, Smeets R,et al. Fetuin -A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in mice. Nephrol Dial Transplant, 2007, 22 ( 6 ) : 1537 - 1546.
-
10Ketteler M, Bongartz P, Westenfeld R, et al. Association of low fetuin- A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross - sectional study. Lancet,2003, 361 (9360) :827 -833.
同被引文献32
-
1白宇,张柳,吕志伟,曲强.辛伐他汀在人骨髓基质干细胞向成骨细胞分化过程中的作用[J].中国骨质疏松杂志,2007,13(6):381-384. 被引量：16
-
2Chwn NX,Moe SM.Vascular calcification in chronic kidney disease[J].Sem Nephrol,2004,24:61-68.
-
3Lien CY,Lee OK,Su Y.Cbfb enhances the osteogenic differentiation of both human and mouse mesenchymal stem cells induced by Cbfα-1 via reducing its ubiquitination-mediated degradation[J].Stem Cells,2007,25:1462-1468.
-
4Block G,Port FK.Calcium phosphate metabolism and cardiovascular disease in patients with chronic kidney disease[J].Semin Dial,2003,16:140-147.
-
5Giachelli CM.The emerging role of phosphate in vascular calcification[J].Kidney Int,2009,75:890-897.
-
6Davies MR,Hruska KA.Pathophysiological mechanisms of vascular calcification in end-stage renal disease[J].Kidney Int,2001,60:472-479.
-
7Lien CY,Lee OK,Su Y.Cbfb enhances the osteogenic differentiation of both human and mouse mesenehymal stem cells induced by Cbfa 1 via reducing its ubiquitination-mediated degradation[J].Stem Cells,2007,25:1462-1468.
-
8Kojima H,Uemura T.Strong and rapid induction of osteoblast differentiation by cbfa1/til-1 overexpression for bone regeneration[J].J Bio Chem,2005,280:2944-2953.
-
9Ishimura E,Taniwaki H,TabataT.elal.Cross-sectional association of serum phosphate with carotid intima-medial thickness in hemodialysis patients[J].Am J Kidney Dis,2005,45:859-865.
-
10Reynolds JL,Joannides AJ,Skepper JN,et al.Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and Phosphate Concentrations:a potential mechanism for accelerated vascular calcification in ESRD[J].J Am Soc Nephrol,2004,15:2857-2867.
引证文献3
-
1李峻岭,王琳,李丽华,李胜范,曹平安.高磷对大鼠血管平滑肌细胞钙化及核心结合因子α1表达的影响[J].大连医科大学学报,2010,32(3):246-250.
-
2李峻岭,李丽华,李胜范,刘明开,姜盛花.骨形态发生蛋白7对高磷诱导的大鼠主动脉平滑肌细胞钙化的影响[J].中华高血压杂志,2010,18(11):1053-1058. 被引量：1
-
3郑小艳,顾鹏,李玲,唐盈,唐雪梅,贺鹏.慢性肾衰竭伴高血压患者与原发性高血压患者颈动脉及眼动脉的高频超声对比研究[J].川北医学院学报,2018,33(1):84-86. 被引量：4
二级引证文献5
-
1刘启艳,詹伟,彭玉.大鼠平滑肌细胞培养研究进展与分析[J].贵阳中医学院学报,2019,41(3):76-82. 被引量：6
-
2陈龙,成家友,周冬梅,王金.血液透析联合杏丁注射液治疗慢性肾衰竭的效果观察及对胃肠激素的影响[J].中南医学科学杂志,2019,47(3):299-302. 被引量：15
-
3孙清,李国英.颈动脉彩超狭窄程度分级在高血压患者筛查中的应用价值分析[J].现代诊断与治疗,2021,32(9):1452-1454.
-
4崔颖超.血压节律杓型和非杓型对PSV、RI的影响[J].吉林医学,2022,43(4):942-944.
-
5潘艳子,马辉,陈新政,杨剑,邱欣.丹红注射液联合尿毒清颗粒对高血压早中期慢性肾衰竭患者的尿蛋白及肾功能的影响[J].药物评价研究,2019,0(9):1818-1821. 被引量：11
-
1滕兰波（综述）,赵久阳（审校）.慢性肾衰竭患者血管钙化机制的研究进展[J].国际泌尿系统杂志,2007,27(2):248-252.
-
2李康华,王朝晖,张宏其,雷光华,廖前德.钙化型腰椎间盘突出症的手术治疗[J].临床骨科杂志,2005,8(1):48-50.
-
3刘红,常明.终末期肾病血管钙化的防治[J].国外医学（泌尿系统分册）,2005,25(3):344-348. 被引量：1
-
4刘翻利,马丽.慢性肾衰竭血管钙化机制研究进展[J].中国现代医生,2014,52(4):154-156. 被引量：6
-
5章斌,史伟.终末期肾病血管钙化机制[J].中华肾脏病杂志,2004,20(2):145-146. 被引量：7
-
6葛丽娜,方炜.终末期肾脏病血管钙化的机制[J].中国中西医结合肾病杂志,2011,12(8):746-747.
-
7伍敏.慢性肾脏病血管钙化机制的研究进展[J].中华医学杂志,2013,93(34):2759-2761. 被引量：3
-
8崔惠军,崔恩.钙质沉着症1例[J].包头医学院学报,2005,21(1):15-15.
-
9陈昕,彭波,陈明.终末期肾病患者血管钙化与钙化抑制物[J].国际泌尿系统杂志,2006,26(1):132-135. 被引量：1
-
10毛毳,李永华,朱永波,张宏社,刘国红,常艳艳.间质性钙质沉着症1例[J].中国医学影像技术,2012,28(6):1178-1178.
